Neurodevice startups target peripheral nervous system

  title={Neurodevice startups target peripheral nervous system},
  author={M. Eisenstein},
  journal={Nature Biotechnology},
  • M. Eisenstein
  • Published 2013
  • Medicine, Biology
  • Nature Biotechnology
  • 865 of Houston, Texas, made an initial €2 ($2.6)-million investment in Cerbomed, and ElectroCore of Basking Ridge, New Jersey, landed $40 million to develop its handheld vagus nerve stimulation (VNS) device from investors that include the Merck Global Healthcare Innovation Fund. Most recently, SetPoint Medical, of Valencia, California, became the first company to be selected for backing by GlaxoSmithKline’s Action Potential fund. Famm says this is only the starting point—his division is… CONTINUE READING
    2 Citations
    Global market for implanted neuroprostheses
    • 7